This paper proposes an ultra-wideband hybrid polarization conversion-absorption (PCA) metasurface with a transmission band for radar cross section (RCS) reduction application. To achieve the in-band transmission of the incident wave and the out-of-band suppression of the scattering wave, the proposed metasurface is composed of a low-frequency PCA array, a high-frequency polarization conversion (PC) array, and a second-order frequency selective surface (FSS). The lumped resistors are used in the PCA array to generate the absorption characteristic, thus giving rise to the reduction of the co-polarization component of the scattering field and meanwhile the elimination of the high-frequency resonances. An interdigital structure is introduced into the PCA array to not only achieve a good transmission for a co-polarization component of the incoming wave but also result in an extra PC band for narrowing the transition band between the transmission window and the high-frequency PCA band. The orthogonal layout of the PCA array and the PC array is used to decrease the interaction between them, thus resulting in an ultra-wideband PCA band. The second-order FSS consisting of a stacked structure is designed to generate a good passband with the steep roll-off and the good out-of-band suppression. The proposed metasurface has an ultra-wideband PCA band, a good transmission band, and narrow transition bands. When the proposed metasurface is arranged into an array in a rotation way, the ultra-wideband RCS reduction performance can be obtained. Simulated and measured results are given to demonstrate a 10 dB RCS reduction band of 3.4-24.6 GHz with a -1 dB transmission band of 8.45-10 GHz.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.